SpaceWar.com - Your World At War
French court hears Agent Orange case against chemical firms
Évry, France, Jan 25 (AFP) Jan 25, 2021
A French court will on Monday hear a case against more than a dozen multinationals, accused by a French-Vietnamese woman of causing grievous harm to her and others by selling the Agent Orange defoliant to the US government which used it to devastating effect in the Vietnam War.

Tran To Nga, born in 1942 in what was then French Indochina, worked as a journalist and activist in Vietnam in her 20s.

She filed the lawsuit in 2014 against 14 firms that made or sold the highly toxic chemical, including Monsanto, now owned by German giant Bayer, and Dow Chemical.

Backed by several NGOs, she accuses the companies of being responsible for injuries sustained by her, her children and countless others, as well as for damage done to the environment.

"A recognition of Vietnamese civilian victims would constitute a legal precedent", said international law specialist Valerie Cabanes.

So far, only military veterans -- from the US, Australia and Korea -- have won compensation for the after-effects of the chemical whose toxic properties Cabanes said were "absolutely phenomenal" at around 13 times the toxicity of herbicides in civilian use such as glyphosate.

Four million people in Vietnam, Laos and Cambodia were exposed to Agent Orange, according to NGOs, over a decade when the US military sprayed an estimated 76 million litres (20 million gallons) of the herbicide and defoliant chemical to halt the advances of communist North Vietnamese troops and deprive enemy combatants of food sources.

The US ended the use of defoliant chemicals in the war in 1971, and withdrew from Vietnam in 1975, defeated by the Viet Cong.

Agent Orange destroyed plants, polluted the soil and poisoned animals, and caused cancer and malformations in humans, NGOs say.

"I'm not fighting for myself, but for my children and the millions of victims," said Tran To Nga, who says that Agent Orange attacked people's immune system.

She herself was suffering from typical Agent Orange effects, including type 2 diabetes and an extremely rare insulin allergy.

She said she also contracted tuberculosis twice, developed a cancer and one of her daughters died of a malformation of the heart.

Every year, some 6,000 children are diagnosed with congenital malformations in Vietnam, Cabanes said.

The multinationals have argued that they could not be held responsible for the use the American military made of their product.

Contacted by AFP, Bayer said that Agent Orange was made "under the sole management of the US government for exclusively military purposes".

The plaintiff and her lawyers are expected to argue that the makers of Agent Orange misled the US government as to its true toxicity.

The trial in the southern Paris suburb of Evry was originally due to open in October, but its start was postponed due to Covid-19 restrictions.

ola/jh/har

Bayer

Monsanto

DOW CHEMICAL


ADVERTISEMENT




Space News from SpaceDaily.com
UK opens competitive bid for GBP 75 million orbital cleanup mission
UK invests $191 mn in European satellite firm Eutelsat
Bearings Used in Space Technologies: Engineering for the Final Frontier

24/7 Energy News Coverage
Atomic 6 receives 2M Space Force award to advance next generation solar arrays
ESA and Neuraspace develop autonomous satellite navigation technologies
Planet secures 240 million euro satellite services contract with German government

Military Space News, Nuclear Weapons, Missile Defense
London, Paris tighten nuclear bond over US, Russia concerns
Iran says cooperation with UN nuclear watchdog will take 'new form'
Six killed in massive Russian drone, missile attack across Ukraine

24/7 News Coverage
Ancient zircon data reveals tectonic origin of Earth's first continental crust
Autonomous sub explores unexplored trench depths to reveal critical mineral clues
Europe launches first geostationary atmospheric sounder to boost extreme weather forecasts



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.